The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment

被引:81
作者
Chang, Nakho [1 ,2 ]
Ahn, Sun Hee [1 ,2 ]
Kong, Doo-Sik [3 ]
Lee, Hye Won [2 ,4 ]
Nam, Do-Hyun [1 ,2 ,3 ]
机构
[1] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 06351, South Korea
[2] Samsung Med Ctr, Inst Refractory Canc Res, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul 06351, South Korea
[4] Samsung Med Ctr, Inst Future Med, Seoul 06351, South Korea
基金
新加坡国家研究基金会;
关键词
Signal transducer and activator of transcription 3; Glioblastoma multiforme; Tumor progression; Tumor microenvironment; Prognosis; Therapeutic target; REGULATORY T-CELLS; EPIDERMAL-GROWTH-FACTOR; PRIMARY INTRACRANIAL TUMORS; NF-KAPPA-B; DNA-BINDING ACTIVITY; STEM-LIKE CELLS; SIGNALING INDUCES APOPTOSIS; COLONY-STIMULATING FACTOR; SMALL-MOLECULE INHIBITOR; PREDICTS POOR-PROGNOSIS;
D O I
10.1016/j.mce.2017.01.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glioblastoma multiforme (GBM) is the most aggressive form of cancer that begins within the brain; generally, the patient has a dismal prognosis and limited therapeutic options. Signal transducer and activator of transcription 3 (STAT3) is a critical mediator of tumorigenesis, tumor progression, and suppression of anti-tumor immunity in GBM. In a high percentage of GBM cells and tumor microenvironments, persistent activation of STAT3 induces cell proliferation, anti-apoptosis, glioma stem cell maintenance, tumor invasion, angiogenesis, and immune evasion. This makes STAT3 an attractive therapeutic target and a prognostic indicator in GBM. Targeting STAT3 affords an opportunity to disrupt multiple pro-oncogenic pathways at a single molecular hub. Unfortunately, there are no successful STAT3 inhibitors currently in clinical trials. However, strong clinical evidence implicating STAT3 as a major factor in GBM justifies the identification of safe and effective strategies for inhibiting STAT3. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 65
页数:13
相关论文
共 260 条
[1]   BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal [J].
Abdouh, Mohamed ;
Facchino, Sabrina ;
Chatoo, Wassim ;
Balasingam, Vijayabalan ;
Ferreira, Jose ;
Bernier, Gilbert .
JOURNAL OF NEUROSCIENCE, 2009, 29 (28) :8884-8896
[2]   The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas [J].
Abou-Ghazal, Mohamed ;
Yang, David S. ;
Qiao, Wei ;
Reina-Ortiz, Chantal ;
Wei, Jun ;
Kong, Ling-Yuan ;
Fuller, Gregory N. ;
Hiraoka, Nobuyoshi ;
Priebe, Waldemar ;
Sawaya, Raymond ;
Heimberger, Amy B. .
CLINICAL CANCER RESEARCH, 2008, 14 (24) :8228-8235
[3]   Roles of STAT3 defined by tissue-specific gene targeting [J].
Akira, S .
ONCOGENE, 2000, 19 (21) :2607-2611
[4]   MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY [J].
AKIRA, S ;
NISHIO, Y ;
INOUE, M ;
WANG, XJ ;
WEI, S ;
MATSUSAKA, T ;
YOSHIDA, K ;
SUDO, T ;
NARUTO, M ;
KISHIMOTO, T .
CELL, 1994, 77 (01) :63-71
[5]   Mechanisms of Local Immunoresistance in Glioma [J].
Albesiano, Emilia ;
Han, James E. ;
Lim, Michael .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (01) :17-+
[6]  
[Anonymous], CANC RES
[7]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[8]   Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line [J].
Ashizawa, Tadashi ;
Akiyama, Yasuto ;
Miyata, Haruo ;
Iizuka, Akira ;
Komiyama, Masaru ;
Kume, Akiko ;
Omiya, Maho ;
Sugino, Takashi ;
Asai, Akira ;
Hayashi, Nakamasa ;
Mitsuya, Koichi ;
Nakasu, Yoko ;
Yamaguchi, Ken .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) :411-418
[9]   Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma [J].
Ashizawa, Tadashi ;
Miyata, Haruo ;
Iizuka, Akira ;
Komiyama, Masaru ;
Oshita, Chie ;
Kume, Akiko ;
Nogami, Masahiro ;
Yagoto, Mika ;
Ito, Ichiro ;
Oishi, Takuma ;
Watanabe, Reiko ;
Mitsuya, Koichi ;
Matsuno, Kenji ;
Furuya, Toshio ;
Okawara, Tadashi ;
Otsuka, Masami ;
Ogo, Naohisa ;
Asai, Akira ;
Nakasu, Yoko ;
Yamaguchi, Ken ;
Akiyama, Yasuto .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (01) :219-227
[10]   STAT3, STAT4, NFATc1, and CTCF Regulate PD-1 through Multiple Novel Regulatory Regions in Murine T Cells [J].
Austin, James W. ;
Lu, Peiyuan ;
Majumder, Parimal ;
Ahmed, Rafi ;
Boss, Jeremy M. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (10) :4876-4886